Combination Immunotherapy Approaches in Metastatic Renal Cell Carcinoma with Favorable Risk Scores: A Meta-Analysis of Individual Patient Data - Top-Institutions - MDSpire

Combination Immunotherapy Approaches in Metastatic Renal Cell Carcinoma with Favorable Risk Scores: A Meta-Analysis of Individual Patient Data

  • By

  • Mattia Alberto Di Civita

  • Daniele Marinelli

  • Valerio Marco Michetti

  • Adele Artemi

  • Andrea Ballario

  • Andrea Torchia

  • Laura Pappalardo

  • Martina Pecoraro

  • Iolanda Speranza

  • Alessandro Sciarra

  • Valeria Panebianco

  • Michela Roberto

  • Daniele Santini

  • January 8, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Medical Oncology
    • Urologic Oncology
    • Immunotherapy Research
  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Immuno-Oncology
    • Genitourinary Cancers
  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Medical Oncology
    • Immunotherapy
    • Kidney Cancer
  • #4

    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

    Baltimore, MD

    Key Differentiators

    • Medical Oncology
    • Immunotherapy
    • Genitourinary Oncology
  • #5

    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

    San Francisco, CA

    Key Differentiators

    • Medical Oncology
    • Immunotherapy
    • Kidney Cancer

Original Source(s)

Related Content